EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DRG Explant Model for Understanding Mechanism of Oxaliplatin-Induced Peripheral Neuropathy and Identifying Potential Therapeutic Targets

Junwei Du, Leland C Sudlow, Igor D Luzhansky, Mikhail Y Berezin

Antioxidants · 10.02.2026 · 15 (2) · 230

DOI: 10.3390/antiox15020230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 10.02.2026. Verfasst von Junwei Du und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mallinckrodt Institute of Radiology, School of Medicine, Washington University, St. Louis, MO 63110, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, NIH/NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxaliplatin-triggered chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating side effect of cancer treatment that limits the efficacy of chemotherapy and negatively impacts patients’ quality of life dramatically. To better understand the mechanisms of CIPN and to screen for potential therapeutic targets, it is critical to have reliable in vitro assays that effectively mirror the neuropathy in vivo. In this study, we established a dorsal root ganglia (DRG) explant model. This model displayed dose-dependent inhibition of neurite outgrowth in response to oxaliplatin, while oxalic acid exhibited no significant impact on the regrowth of DRG. The robustness of this assay was further demonstrated by the inhibition of OCT2 transporter, which facilitates oxaliplatin accumulation in neurons, largely restoring the neurite regrowth capacity. Using this model, we revealed that oxaliplatin triggered a substantial increase of oxidative stress in DRG. Notably, inhibition of TXNIP with verapamil reduced oxidative stress levels. Our results demonstrated the use of DRG explants as an efficient model to study the mechanisms of CIPN and screen for potential treatments.

Schlagwörter

Stichwörter der Autor:innen

dorsal root gangliaoxaliplatin induced peripheral neuropathyoxidative stress

Autor:innen und Institutionen

  • Mallinckrodt Institute of Radiology, School of Medicine, Washington University, St. Louis, MO 63110, USA.
  • Institute of Materials Science & Engineering, Washington University, St. Louis, MO 63130, USA.

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS
  • NIH/NCI
  • NIH/NINDS

Zitieren

APA

Du, J., Sudlow, L. C., Luzhansky, I. D., & Berezin, M. Y. (2026). DRG Explant Model for Understanding Mechanism of Oxaliplatin-Induced Peripheral Neuropathy and Identifying Potential Therapeutic Targets. Antioxidants, 15(2), 230. https://doi.org/10.3390/antiox15020230

Vancouver

Du J, Sudlow LC, Luzhansky ID, Berezin MY. DRG Explant Model for Understanding Mechanism of Oxaliplatin-Induced Peripheral Neuropathy and Identifying Potential Therapeutic Targets. Antioxidants. 2026;15(2):230. doi:10.3390/antiox15020230

BibTeX
@article{Du2026,
  author = {Du, Junwei and Sudlow, Leland C and Luzhansky, Igor D and Berezin, Mikhail Y},
  title = {DRG Explant Model for Understanding Mechanism of Oxaliplatin-Induced Peripheral Neuropathy and Identifying Potential Therapeutic Targets},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {2},
  pages = {230},
  doi = {10.3390/antiox15020230}
}
Kostenlos starten →